Moxetumomab
Moxetumomab is an anti-CD22 human IgG1 κ monoclonal antibody. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control[2].
Product Specifications
CAS Number
1622075-65-3
UNSPSC
12352203
Target
ADC Antibody; CD22
Type
Inhibitory Antibodies
Related Pathways
Antibody-drug Conjugate/ADC Related; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/moxetumomab.html
Purity
99.77
Solubility
H2O
Smiles
[Moxetumomab]
Molecular Weight
(146.14 kDa)
References & Citations
[1]Robert J Kreitman, et al. Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL) : long-term follow-up from the pivotal trial. J Hematol Oncol. 2021 Feb 24;14 (1) :35.|[2]Sohita Dhillon. Moxetumomab Pasudotox: First Global Approval. Drugs. 2018 Nov;78 (16) :1763-1767.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2556703 1.0 µg DNA
TTYH1 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 
